Kim RD - Search Results

1

Phase I dose-escalation study of copanlisib in combination with gemcitabine or cisplatin plus gemcitabine in patients with advanced cancer.

Kim RD, Alberts SR, Peña C, Genvresse I, Ajavon-Hartmann A, Xia C, Kelly A, Grilley-Olson JE. Kim RD, et al. Br J Cancer. 2018 Feb 20;118(4):462-470. doi: 10.1038/bjc.2017.428. Epub 2018 Jan 18. Br J Cancer. 2018. PMID: 29348486 Free PMC article. Clinical Trial.

2

Second-line therapy for gemcitabine-refractory pancreatic cancer: is there a standard?

Almhanna K, Kim R. Almhanna K, et al. Oncology (Williston Park). 2008 Sep;22(10):1176-83; discussion 1190, 1192, 1196. Oncology (Williston Park). 2008. PMID: 18935928 Free article. Review.

3

To give or not to give anti-epidermal growth factor receptor (EGFR) monoclonal antibodies to patients with KRAS G13D mutation in advanced colorectal cancer.

Kim R, Kubal T. Kim R, et al. Clin Colorectal Cancer. 2012 Jun;11(2):85-7. doi: 10.1016/j.clcc.2011.10.005. Epub 2011 Dec 9. Clin Colorectal Cancer. 2012. PMID: 22169039 Review. No abstract available.

4

A phase II study of RO4929097 in metastatic colorectal cancer.

Strosberg JR, Yeatman T, Weber J, Coppola D, Schell MJ, Han G, Almhanna K, Kim R, Valone T, Jump H, Sullivan D. Strosberg JR, et al. Eur J Cancer. 2012 May;48(7):997-1003. doi: 10.1016/j.ejca.2012.02.056. Epub 2012 Mar 23. Eur J Cancer. 2012. PMID: 22445247 Free PMC article. Clinical Trial.

5

Predictive and prognostic roles of ribonucleotide reductase M1 in resectable pancreatic adenocarcinoma.

Xie H, Jiang W, Jiang J, Wang Y, Kim R, Liu X, Liu X. Xie H, et al. Cancer. 2013 Jan 1;119(1):173-81. doi: 10.1002/cncr.27715. Epub 2012 Jun 26. Cancer. 2013. PMID: 22736490 Free article.

6

Carboplatin and paclitaxel treatment is effective in advanced anal cancer.

Kim R, Byer J, Fulp WJ, Mahipal A, Dinwoodie W, Shibata D. Kim R, et al. Oncology. 2014;87(2):125-32. doi: 10.1159/000361051. Epub 2014 Jul 8. Oncology. 2014. PMID: 25012155

7

Everolimus and pasireotide for advanced and metastatic hepatocellular carcinoma.

Sanoff HK, Kim R, Ivanova A, Alistar A, McRee AJ, O'Neil BH. Sanoff HK, et al. Invest New Drugs. 2015 Apr;33(2):505-9. doi: 10.1007/s10637-015-0209-7. Epub 2015 Jan 23. Invest New Drugs. 2015. PMID: 25613083 Free PMC article. Clinical Trial.

8

Phase I study of combination of pasireotide LAR + gemcitabine in locally advanced or metastatic pancreatic cancer.

Suleiman Y, Mahipal A, Shibata D, Siegel EM, Jump H, Fulp WJ, Springett GM, Kim R. Suleiman Y, et al. Cancer Chemother Pharmacol. 2015 Sep;76(3):481-7. doi: 10.1007/s00280-015-2814-8. Epub 2015 Jul 1. Cancer Chemother Pharmacol. 2015. PMID: 26126727 Clinical Trial.

9

Phase I trial of combination of FOLFIRI and pasireotide, a somatostatin analogue, in advanced gastrointestinal malignancies.

Mahipal A, Shibata D, Siegel E, Springett G, Almhanna K, Fulp W, Williams-Elson I, Kim R. Mahipal A, et al. Invest New Drugs. 2015 Oct;33(5):1093-9. doi: 10.1007/s10637-015-0277-8. Epub 2015 Aug 16. Invest New Drugs. 2015. PMID: 26275531 Free PMC article. Clinical Trial.

10

Phase I study of pre-operative continuous 5-FU and sorafenib with external radiation therapy in locally advanced rectal adenocarcinoma.

Kim R, Prithviraj GK, Shridhar R, Hoffe SE, Jiang K, Zhao X, Chen DT, Almhanna K, Strosberg J, Campos T, Shibata D. Kim R, et al. Radiother Oncol. 2016 Feb;118(2):382-6. doi: 10.1016/j.radonc.2016.01.018. Epub 2016 Feb 6. Radiother Oncol. 2016. PMID: 26861740 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

211 results

Search Page

Filters